IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 278 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $148,000 | +5.7% | 15,488 | +22.1% | 0.01% | +28.6% |
| Q2 2022 | $140,000 | -52.1% | 12,685 | -27.7% | 0.01% | -56.2% |
| Q1 2022 | $292,000 | -2.7% | 17,538 | +11.7% | 0.02% | +45.5% |
| Q4 2021 | $300,000 | +6.8% | 15,700 | +37.6% | 0.01% | -26.7% |
| Q3 2021 | $281,000 | -31.1% | 11,413 | -11.5% | 0.02% | -34.8% |
| Q1 2021 | $408,000 | -27.3% | 12,900 | +6.6% | 0.02% | -51.1% |
| Q4 2020 | $561,000 | +55.0% | 12,100 | +10.0% | 0.05% | +20.5% |
| Q3 2020 | $362,000 | +27.5% | 11,000 | +15.8% | 0.04% | +14.7% |
| Q1 2020 | $284,000 | +30.3% | 9,500 | -20.8% | 0.03% | +161.5% |
| Q3 2019 | $218,000 | – | 12,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 12,201,261 | $203,150,000 | 4.07% |
| Paradigm Biocapital Advisors LP | 907,428 | $15,109,000 | 4.00% |
| Avoro Capital Advisors LLC | 9,125,000 | $151,931,000 | 2.77% |
| Logos Global Management LP | 1,000,000 | $16,650,000 | 2.16% |
| Avidity Partners Management LP | 6,043,219 | $100,620,000 | 2.10% |
| Orbimed Advisors | 6,633,006 | $110,440,000 | 1.79% |
| Parametrica Management Ltd | 134,679 | $2,240,000 | 1.66% |
| Boxer Capital, LLC | 1,935,133 | $32,220,000 | 1.66% |
| Fairmount Funds Management LLC | 389,588 | $6,487,000 | 1.53% |
| Long Focus Capital Management, LLC | 705,000 | $11,738,000 | 1.51% |